2784 Stock Overview
Through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Alfresa Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,256.00 |
| 52 Week High | JP¥2,554.50 |
| 52 Week Low | JP¥1,929.00 |
| Beta | 0 |
| 11 Month Change | -1.05% |
| 3 Month Change | -3.92% |
| 1 Year Change | -5.69% |
| 33 Year Change | 41.00% |
| 5 Year Change | -3.26% |
| Change since IPO | 147.23% |
Recent News & Updates
Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations
Nov 21
Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results
Nov 11Does Alfresa Holdings (TSE:2784) Deserve A Spot On Your Watchlist?
Oct 22Recent updates
Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations
Nov 21Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results
Nov 11Does Alfresa Holdings (TSE:2784) Deserve A Spot On Your Watchlist?
Oct 22The Returns On Capital At Alfresa Holdings (TSE:2784) Don't Inspire Confidence
Oct 08Investor Optimism Abounds Alfresa Holdings Corporation (TSE:2784) But Growth Is Lacking
Jul 30Alfresa Holdings (TSE:2784) Seems To Use Debt Rather Sparingly
Jul 12We Ran A Stock Scan For Earnings Growth And Alfresa Holdings (TSE:2784) Passed With Ease
Jun 25Alfresa Holdings (TSE:2784) Will Be Looking To Turn Around Its Returns
Jun 06Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye
May 22Is There An Opportunity With Alfresa Holdings Corporation's (TSE:2784) 32% Undervaluation?
Apr 19Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 12Alfresa Holdings' (TSE:2784) Dividend Will Be Increased To ¥35.00
Feb 27Shareholder Returns
| 2784 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.8% | -1.3% | -0.4% |
| 1Y | -5.7% | -6.5% | 11.4% |
Return vs Industry: 2784 exceeded the JP Healthcare industry which returned -6.5% over the past year.
Return vs Market: 2784 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
| 2784 volatility | |
|---|---|
| 2784 Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2784 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2784's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 12,517 | Ryuji Arakawa | www.alfresa.com |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.
Alfresa Holdings Corporation Fundamentals Summary
| 2784 fundamental statistics | |
|---|---|
| Market cap | JP¥420.34b |
| Earnings (TTM) | JP¥31.77b |
| Revenue (TTM) | JP¥2.89t |
13.3x
P/E Ratio0.1x
P/S RatioIs 2784 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2784 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.89t |
| Cost of Revenue | JP¥2.68t |
| Gross Profit | JP¥209.46b |
| Other Expenses | JP¥177.68b |
| Earnings | JP¥31.77b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 10, 2025
| Earnings per share (EPS) | 170.00 |
| Gross Margin | 7.26% |
| Net Profit Margin | 1.10% |
| Debt/Equity Ratio | 6.1% |
How did 2784 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield18%
Payout RatioDoes 2784 pay a reliable dividends?
See 2784 dividend history and benchmarks| Alfresa Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 05 2024 |
| Days until Ex dividend | 56 days |
| Days until Dividend pay date | 13 days |
Does 2784 pay a reliable dividends?
See 2784 dividend history and benchmarks